Clinical Trial Update: Inflammation and Co-Infections in D²EFT [Phase 4]

View source ↗

Summary

A Phase 4 trial examining inflammation and co-infections in HIV/AIDS with multiple herpesvirus-related infections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections
• HIV Infection and Aids
• Human Herpesvirus 4 Infections
• Human Herpesvirus Infection
• Human Papillomavirus Infections

Snippet

Sponsor: Kirby Institute | Conditions: HIV-infection/Aids, Human Herpesvirus 4 Infections | Phase 4 | Status: WITHDRAWN